These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3121243

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L, Naumann P, Crea A.
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [Abstract] [Full Text] [Related]

  • 3. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S, Sparham PD, Spencer RC.
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [Abstract] [Full Text] [Related]

  • 4. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Heifets LB, Lindholm-Levy PJ.
    Tubercle; 1987 Dec; 68(4):267-76. PubMed ID: 3138801
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M, Rodriguez F, Villalba R, Benavente MC, Gonzalez AI.
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J, Mormède M, Fourche J, Bébéar C.
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [Abstract] [Full Text] [Related]

  • 7. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
    Rastogi N, Goh KS, David HL.
    Ann Inst Pasteur Microbiol; 1988 Oct; 139(2):233-7. PubMed ID: 3165641
    [No Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
    Casal M, Gutierrez J, González J, Ruiz P.
    Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964
    [Abstract] [Full Text] [Related]

  • 9. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ, Mallet MN, Gulian C, Terriou P, Lagier P, de Micco P.
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [Abstract] [Full Text] [Related]

  • 10. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [Abstract] [Full Text] [Related]

  • 11. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Young LS, Berlin OG, Inderlied CB.
    Am J Med; 1987 Apr 27; 82(4A):23-6. PubMed ID: 3107379
    [Abstract] [Full Text] [Related]

  • 12. MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.
    Heifets LB, Lindholm-Levy PJ.
    Antimicrob Agents Chemother; 1990 May 27; 34(5):770-4. PubMed ID: 2113793
    [Abstract] [Full Text] [Related]

  • 13. In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    Berlin OG, Young LS, Bruckner DA.
    J Antimicrob Chemother; 1987 May 27; 19(5):611-5. PubMed ID: 3112095
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of five new quinolones against cultivable mycobacteria.
    Pattyn SR, Van Caekenberghe DL, Verhoeven JR.
    Eur J Clin Microbiol; 1987 Oct 27; 6(5):572-3. PubMed ID: 3125049
    [No Abstract] [Full Text] [Related]

  • 15. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H, Sato K, Tomioka H, Watanabe T.
    Kekkaku; 1987 May 27; 62(5):287-94. PubMed ID: 3114537
    [No Abstract] [Full Text] [Related]

  • 16. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
    Trimble KA, Clark RB, Sanders WE, Frankel JW, Cacciatore R, Valdez H.
    J Antimicrob Chemother; 1987 May 27; 19(5):617-22. PubMed ID: 3112096
    [Abstract] [Full Text] [Related]

  • 17. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
    Fenlon CH, Cynamon MH.
    Antimicrob Agents Chemother; 1986 Mar 27; 29(3):386-8. PubMed ID: 2940969
    [Abstract] [Full Text] [Related]

  • 18. [Studies on the ofloxacin resistance of tubercle bacilli].
    Tsukamura M, Mizuno S.
    Kekkaku; 1985 Oct 27; 60(10):517-21. PubMed ID: 3935845
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
    Gay JD, DeYoung DR, Roberts GD.
    Antimicrob Agents Chemother; 1984 Jul 27; 26(1):94-6. PubMed ID: 6236748
    [Abstract] [Full Text] [Related]

  • 20. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
    Foroumadi A, Soltani F.
    Boll Chim Farm; 2003 Jul 27; 142(6):248-50. PubMed ID: 14606264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.